【Golden Ten Data Organization: Daily US Stock Market News Brief (November 29, Friday)】
Individual Stock News
1. ASML (ASML.O) has received implied approval for clinical trials from the National Medical Products Administration for its new drug AZD5462, which is intended for the treatment of heart failure.
2. The 2024 National Medical Insurance Catalog shows that AstraZeneca (AZN.O) negotiated the inclusion of the 'breast cancer miracle drug' DS8201, an injection of trastuzumab deruxtecan. Previously, the drug failed to enter the 2023 medical insurance catalog after being listed for formal review in 2023.
3. Sources say BlackRock (BLK.N) is close to finalizing a deal to acquire private credit group HPS Investment Partners, with a final price approaching $12 billion.
4. According to The Information: Amazon (AMZN.O) is developing a video artificial intelligence model to hedge its dependence on Anthropic.
5. Sources say the Federal Trade Commission (FTC) has launched an antitrust investigation into Microsoft (MSFT.O), covering the company's cloud computing and software licensing business, as well as cybersecurity and artificial intelligence products.
6. Vale (VALE.N): The board has approved a dividend of approximately 0.52 Brazilian reais per share.
7. Salesforce (CRM.N) data from Thursday shows that online sales during the first half of the US Thanksgiving holiday increased by about 4%, compared to a 2% increase in the same period last year.
8. Miniso (MNSO.N): The company's revenue for the first three quarters was 12.28 billion yuan, an increase of 22.8% year-on-year.
9. Bilibili (BILI.O) pre-market rose 2%, with reports that Taobao officially livestreamed sales on Bilibili.
10. The Canadian Competition Bureau has filed a lawsuit against Google (GOOG.O), accusing it of anti-competitive behavior in online advertising in Canada.
11. India is reportedly notifying Volkswagen of tax evasion. (Source: Golden Ten Data)